Roche faced a regulatory setback today as the U.S. FDA issued a Complete Response Letter (CRL) for its bid to expand Columvi (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for certain DLBCL patients...
Sun Pharma announced that its monoclonal antibody drug ILUMYA (tildrakizumab 100 mg) has demonstrated favorable results in two Phase 3 clinical trials in active psoriatic arthritis
Top-line findings from two Phase 3 clinical trials assessing the safety and effectiveness of tildrakizumab 100 mg (ILUMYA) given over a 24-week period for the treatment of active psoriatic arthritis were released today by Sun Pharmaceutical
.png)
India is going to change the microbial contamination limits as per Schedule M in the Drugs and Cosmetics Rules to the global WHO limits in a major initiative to improve pharmaceutical manufacturing standards. The decision was taken at the Drugs...
In a breakthrough for health care, Kozhikode has become the first district in Kerala to provide continuous glucose monitoring (CGM) systems free of charge to children diagnosed with Type 1 Diabetes (T1D)...
Indian Council of Medical Research (ICMR), along with Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR) is leading the formulation of a new indigenous malaria vaccine called AdFalciVax.
.jpeg)
The critical momentum to the biomanufacturing sector in India is being spurred by the fact that Danaher India, a subsidiary of world science and technology giant Danaher Corporation, has entered into a strategic alliance with the Translational Health
In an interaction with India Pharma Outlook, Dr. Mohan Keshavamurthy, Principal Director – Renal Sciences at Fortis Healthcare, discusses how robotic surgery is revolutionizing kidney transplants in India by improving surgical precision, reducing war
Apollo Home Healthcare in collaboration with the Apollo Indraprastha Hospitals has launched a integrated palliative care at home service in New Delhi. This is a ground breaking step towards meeting the increasing demands for compassionate...
Pharma company Corona Remedies is set to further bolster its presence in cardiology and hormones for women with seven major brands purchased from Bayer's Indian pharmaceuticals division. The acquisition would take effect on July 16, 2025, and is...
.jpg)
, CDSCO.jpg)